Your browser doesn't support javascript.
loading
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan.
Afiliação
  • Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
  • Colombel JF; Icahn School of Medicine, Mount Sinai, New York City, NY, USA.
  • Lukas M; Clinical and Research Centre for Inflammatory Bowel Diseases, ISCARE IVF Clinical Center Ceskomoravská, Prague, Czech Republic.
  • Gisbert JP; Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
  • D'Haens G; Department of Gastroenterology, Imelda Hospital, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Hayee B; King's College Hospital Denmark Hill London, London, UK.
  • Panaccione R; University of Calgary, Calgary, AB, Canada.
  • Kim HS; Department of Internal Medicine 20, Yonsei University, Wonju, South Korea.
  • Reinisch W; Medical University of Vienna, Vienna, Austria.
  • Tyrrell H; Roche, Welwyn Garden City, UK.
  • Oh YS; Genentech, South San Francisco, CA, USA.
  • Tole S; Genentech, South San Francisco, CA, USA.
  • Chai A; Genentech, South San Francisco, CA, USA.
  • Chamberlain-James K; Roche, Welwyn Garden City, UK.
  • Tang MT; Genentech, South San Francisco, CA, USA.
  • Schreiber S; Christian-Albrechts University, Kiel, Germany. Electronic address: s.schreiber@mucosa.de.
Lancet Gastroenterol Hepatol ; 7(2): 118-127, 2022 02.
Article em En | MEDLINE | ID: mdl-34798038

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Anticorpos Monoclonais Humanizados / Infliximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Anticorpos Monoclonais Humanizados / Infliximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article